Editorial

DOI: 10.4244/EIJ-E-24-00051

Hybrid quantification of absolute perfusion requires accurate measurement of myocardial mass

Nils P. Johnson1, MD, MS; K. Lance Gould1, MD

Subendocardial and transmural perfusion improve after aortic valve replacement in aortic stenosis. Accordingly, in this issue of EuroIntervention, the publication by Gallinoro et al1 on longitudinal coronary physiology before and after transcatheter aortic valve implantation (TAVI) raises a critical point regarding the quantification of absolute myocardial perfusion. As summarised in Figure 1, we argue that the algorithm for determining absolute myocardial mass from computed tomography (CT) imaging needs validation and currently appears to be inaccurate.

As clearly stated by the developers of invasive continuous thermodilution: “Absolute flow, expressed in mL/min is meaningless because the myocardial distribution to be perfused is unknown and varies widely between different arteries and different subjects”2. Two possible normalisations exist. First, flow during stress conditions can be expressed as a unitless multiple of resting conditions, i.e., coronary flow reserve (CFR). Second, absolute flow (mL/min) can be divided by the amount of distal myocardial mass (g) to calculate perfusion (mL/min/g).

Cardiac positron emission tomography (PET) or magnetic resonance imaging (CMR) intrinsically quantify myocardial perfusion due to their data acquisition and flow models. Other techniques, such...

Sign in to read
the full article

Forgot your password?
No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Volume 20 Number 19
Oct 7, 2024
Volume 20 Number 19
View full issue


Key metrics

Suggested by Cory

Clinical research

10.4244/EIJ-D-22-00621 Feb 20, 2023
Long-term changes in coronary physiology after aortic valve replacement
Sabbah M et al
free

Editorial

10.4244/EIJ-E-22-00052 Feb 20, 2023
Understanding the mechanism of improved CFR after TAVR/SAVR – the importance of basal flow
Kern M and Seto AH
free

Reply to the letter to the editor

10.4244/EIJ-D-22-01031 Mar 20, 2023
Reply: Coronary physiology in severe aortic stenosis: solely a matter of increased coronary resting flow?
Sabbah M et al
free

Letter to the editor

10.4244/EIJ-D-22-00998 Mar 20, 2023
Letter: Coronary physiology in severe aortic stenosis: solely a matter of increased coronary resting flow?
Minten L et al
free

Original Research

10.4244/EIJ-D-24-00075 Oct 7, 2024
Absolute coronary flow and microvascular resistance before and after transcatheter aortic valve implantation
Gallinoro E et al

Editorial

10.4244/EIJ-E-23-00068 Mar 4, 2024
Acute changes in microvascular resistance after treating aortic stenosis
Johnson N and Eerdekens R
free

10.4244/AIJV14I2A19 Jun 20, 2018
Time for caution interpreting coronary physiology in aortic stenosis?
Davies J and Piek J
free

Clinical research

10.4244/EIJ-D-23-00735 Nov 19, 2023
Characterisation of coronary microvascular dysfunction in patients with severe aortic stenosis undergoing TAVI
Scarsini R et al
free
Trending articles
172.65

Focus article

10.4244/EIJY19M08_01 Jan 17, 2020
EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion – an update
Glikson M et al
free
95.95

State-of-the-Art

10.4244/EIJ-D-24-00066 Apr 21, 2025
Management of complications after valvular interventions
Bansal A et al
free
76.3

State-of-the-Art

10.4244/EIJ-D-23-00840 Sep 2, 2024
Aortic regurgitation: from mechanisms to management
Baumbach A et al
free
63

Image – Interventional flashlight

10.4244/EIJ-D-22-00074 Jun 3, 2022
Transcatheter aortic valve repair for aortic regurgitation with the Cusper device
Feld Y et al
free
58.2

Clinical research

10.4244/EIJ-D-23-00344 Sep 18, 2023
Clinical outcomes of TAVI with the Myval balloon-expandable valve for non-calcified aortic regurgitation
Sanchez-Luna JP et al
free
49.1

Original Research

10.4244/EIJ-D-25-00331 May 21, 2025
One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
Jang Y et al
open access
49.1

Original Research

10.4244/EIJ-D-25-00331 Jul 21, 2025
One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
Jang Y et al
open access
31.1

Expert Review

10.4244/EIJ-D-24-00535 May 5, 2025
Catheter-based techniques for pulmonary embolism treatment
Costa F et al
30.4

Clinical Research

10.4244/EIJ-D-21-00363 Jan 28, 2022
Membranous septum morphology and risk of conduction abnormalities after transcatheter aortic valve implantation
Jørgensen T et al
free
X

PCR
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved